Ability to downregulate the level of cyclin-dependent kinase inhibitor p27Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway
Leukemia & lymphoma.
2017 Jan ;
58 (1) :
199-203.
[epub] 20160607
Language English Country United States Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
Persistent link
https://www.medvik.cz/link/pmid27268868
- MeSH
- Ataxia Telangiectasia Mutated Proteins genetics metabolism MeSH
- Cell Cycle genetics MeSH
- Leukemia, Lymphocytic, Chronic, B-Cell genetics metabolism MeSH
- Adult MeSH
- Down-Regulation * MeSH
- Cyclin-Dependent Kinase Inhibitor p27 genetics metabolism MeSH
- Humans MeSH
- Mutation MeSH
- Tumor Suppressor Protein p53 genetics metabolism MeSH
- DNA Damage * MeSH
- Flow Cytometry MeSH
- Aged MeSH
- Signal Transduction genetics MeSH
- Blotting, Western MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Aged MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Ataxia Telangiectasia Mutated Proteins MeSH
- Cyclin-Dependent Kinase Inhibitor p27 MeSH
- Tumor Suppressor Protein p53 MeSH
Department of Biology Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic
Department of Immunology Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic
e Department of Surgery University of Alabama at Birmingham Birmingham AL USA
Comment In
References provided by Crossref.org
